Dawson James Analyst Ratings & Stock Recommendations

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Dawson James. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Dawson James.

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
7/11/2019Dawson JamesReiteratesDelMar Pharmaceuticals (DMPI)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
7/1/2019Dawson JamesInitiatesIsoRay (ISR)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
7/2/2019Dawson JamesInitiatesAdamis Pharmaceuticals (ADMP)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
5/13/2019Dawson JamesReiteratesSpring Bank Pharmaceuticals (SBPH)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
4/12/2019Dawson JamesReiteratesAdial Pharmaceuticals (ADIL)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
4/12/2019Dawson JamesInitiatesMYnd Analytics (MYND)Buy $4.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/8/2019Dawson JamesReiteratesPayment Data Systems (PYDS)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
3/29/2019Dawson JamesReiteratesFinjan (FNJN)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
2/27/2019Dawson JamesReiteratesCaladrius Biosciences (CLBS)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
2/7/2019Dawson JamesReiteratesBioTime (BTX)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
2/7/2019Dawson JamesInitiatesBioTime (BTX)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
1/9/2019Dawson JamesInitiatesNanoVibronix (NAOV)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
12/28/2018Dawson JamesReiteratesinTest (INTT)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
12/28/2018Dawson JamesReiteratesinTEST (INTT)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
12/27/2018Dawson JamesInitiatesxG Technology (XGTI)Buy $1.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/21/2018Dawson JamesReiteratesSito Mobile (SITO)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
12/20/2018Dawson JamesReiteratesOrgenesis (ORGS)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
12/19/2018Dawson JamesReiteratesSilverSun Technologies (SSNT)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
12/18/2018Dawson JamesReiteratesBrainstorm Cell Therapeutics (BCLI)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
12/20/2018Dawson JamesInitiatesOrgenesis (ORGS)Buy -> BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
12/18/2018Dawson JamesReiteratesGSE Systems, Inc. (NASDAQ) (GVP)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
12/11/2018Dawson JamesReiteratesFTE Networks (FTNW)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
12/11/2018Dawson JamesReiteratesFTE Networks (FTNW)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018Dawson JamesReiteratesWidePoint (WYY)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018Dawson JamesReiteratesWireless Telecom Group (WTT)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018Dawson JamesReiteratesWidePoint (WYY)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018Dawson JamesReiteratesWireless Telecom Group (WTT)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Dawson JamesDowngradesOncoSec Medical (ONCS)Buy -> NeutralLowView Rating Details  Share on Twitter  Share on StockTwits
10/29/2018Dawson JamesInitiatesAlaska Communications Systems Group (ALSK)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
10/25/2018Dawson JamesReiteratesPareteum (TEUM)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
10/24/2018Dawson JamesInitiatesPayment Data Systems (PYDS)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
10/22/2018Dawson JamesInitiatesCinedigm (CIDM)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
10/17/2018Dawson JamesInitiatesInterpace Diagnostics Group (IDXG)Buy $4.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/10/2018Dawson JamesReiteratesFennec Pharmaceuticals (FRX)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
10/11/2018Dawson JamesInitiatesAdial Pharmaceuticals (ADIL)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
10/11/2018Dawson JamesInitiatesFennec Pharmaceuticals (FENC)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018Dawson JamesReiteratesBiocept (BIOC)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Dawson JamesReiteratesAdial Pharmaceuticals (ADIL)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
10/2/2018Dawson JamesInitiatesLuna Innovations (LUNA)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
9/27/2018Dawson JamesReiteratesSigma Labs (SGLB)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
9/4/2018Dawson JamesInitiatesSTRATA Skin Sciences (SSKN)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
8/28/2018Dawson JamesInitiatesCHF Solutions (CHFS)Buy $3.30HighView Rating Details  Share on Twitter  Share on StockTwits
7/16/2018Dawson JamesReiteratesOncoSec Medical (ONCS)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
7/10/2018Dawson JamesInitiatesFusion Telecommunications International (FSNN)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
6/25/2018Dawson JamesReiteratesVeru (VERU)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
6/19/2018Dawson JamesReiteratesIMV (IMV)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
6/19/2018Dawson JamesReiteratesIMV (IMV)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
6/4/2018Dawson JamesReiteratesLivexlive Media (LIVX)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
5/29/2018Dawson JamesReiteratesAltimmune (ALT)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
5/22/2018Dawson JamesReiteratesFinjan (FNJN)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
5/15/2018Dawson JamesInitiatesChampions Oncology (CSBR)Buy $10.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/6/2018Dawson JamesDowngradesCancer Genetics (CGIX)Buy -> NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
1/29/2018Dawson JamesReiteratesAcasti Pharma (ACST)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
10/16/2017Dawson JamesReiteratesCEL-SCI (CVM)NeutralN/AView Rating Details  Share on Twitter  Share on StockTwits
9/27/2017Dawson JamesReiteratesPulmatrix (PULM)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
9/22/2017Dawson JamesReiteratesPareteum (TEUM)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
9/5/2017Dawson JamesReiteratesPAVmed (PAVM)Buy $10.10HighView Rating Details  Share on Twitter  Share on StockTwits
8/23/2017Dawson JamesReiteratesTonix Pharmaceuticals (TNXP)Buy $90.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/8/2017Dawson JamesReiteratesDelMar Pharmaceuticals (DMPI)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
8/7/2017Dawson JamesReiteratesSpring Bank Pharmaceuticals (SBPH)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
8/3/2017Dawson JamesReiteratesESSA Pharma (EPIX)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
7/25/2017Dawson JamesReiteratesOnconova Therapeutics (ONTX)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
7/6/2017Dawson JamesReiteratesOncoSec Medical (ONCS)Buy $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/27/2017Dawson JamesInitiatesCancer Genetics (CGIX)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
6/19/2017Dawson JamesReiteratesOpGen (OPGN)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
11/6/2016Dawson JamesReiteratesSpring Bank Pharmaceuticals (SBPH)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
5/24/2016Dawson JamesReiteratesParnell Pharmaceuticals (PARNF)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
3/11/2016Dawson JamesReiteratesCEL-SCI (CVM)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
2/29/2016Dawson JamesReiteratesNeurometrix (NURO)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
2/9/2016Dawson JamesReiteratesEnzo Biochem (ENZ)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
6/12/2015Dawson JamesLowers TargetWindstream (WIN)Neutral$10.50 -> $8.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/6/2015Dawson JamesInitiatesSoleno Therapeutics (SLNO)Buy $63.50N/AView Rating Details  Share on Twitter  Share on StockTwits
3/2/2015Dawson JamesInitiatesCEL-SCI (CVM)Buy $3.00N/AView Rating Details  Share on Twitter  Share on StockTwits
6/25/2014Dawson JamesInitiatesPulmatrix (PULM)Buy $120.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/14/2014Dawson JamesInitiatesAxoGen (AXGN)Buy $5.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/14/2014Dawson JamesInitiatesNeoGenomics (NEO)Buy $6.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/9/2013Dawson JamesInitiatesArca Biopharma (ABIO)Buy $3.75N/AView Rating Details  Share on Twitter  Share on StockTwits
3/12/2013Dawson JamesReiteratesAgenus (AGEN)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
3/12/2013Dawson JamesDowngradesMEDNAX (MD)Buy -> Neutral $80.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/26/2013Dawson JamesInitiatesArrowhead Pharmaceuticals (ARWR)Buy $4.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/20/2012Dawson JamesInitiatesAtossa Genetics (ATOS)Outperform $120.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/12/2012Dawson JamesReiteratesCelgene (CELG)Market Outperform $51.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/4/2012Dawson JamesDowngradesThe GEO Group (GEO)Market PerformN/AView Rating Details  Share on Twitter  Share on StockTwits
11/27/2012Dawson JamesInitiatesNavidea Biopharmaceuticals (NAVB)OutperformN/AView Rating Details  Share on Twitter  Share on StockTwits
11/27/2012Dawson JamesInitiatesCelsion (CLSN)Outperform $126.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/27/2012Dawson JamesInitiatesSpectrum Pharmaceuticals (SPPI)Outperform $15.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/27/2012Dawson JamesInitiatesSarepta Therapeutics (SRPT)OutperformN/AView Rating Details  Share on Twitter  Share on StockTwits
11/27/2012Dawson JamesInitiatesRockwell Medical (RMTI)Outperform $12.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/27/2012Dawson JamesInitiatesAgenus (AGEN)OutperformN/AView Rating Details  Share on Twitter  Share on StockTwits
11/27/2012Dawson JamesInitiatesAffymax (AFFY)Outperform $32.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/27/2012Dawson JamesDowngradesCytokinetics (CYTK)OutperformN/AView Rating Details  Share on Twitter  Share on StockTwits
7/6/2012Dawson JamesLowers TargetGalectin Therapeutics (GALT)Buy $3.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/26/2012Dawson JamesInitiatesTonix Pharmaceuticals (TNXP)Buy $40.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/28/2011Dawson JamesLowers TargetNetflix (NFLX)Sell$16.50 -> $7.1429N/AView Rating Details  Share on Twitter  Share on StockTwits
6/23/2011Dawson JamesInitiatesHalcon Resources (HK)Buy $180.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/22/2011Dawson JamesInitiatesImmunoCellular Therapeutics (IMUC)Buy $5.00N/AView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Saturday at 01:40 PM ET.

MarketBeat Community Rating for Dawson James

Community Ranking:  1.9 out of 5 (star half star)
Outperform Votes:  14,705 (Vote Outperform)
Underperform Votes:  24,986 (Vote Underperform)
Total Votes:  39,691
MarketBeat's community ratings are surveys of what our community members think about Dawson James and other research firms. Vote "Outperform" if you believe Dawson James's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Dawson James's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel